Skip to content

Clinical trials

Colorectal Neoplasms trials in France with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colorectal Neoplasms Phase: Not applicable Country / region: France Clear all

104 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20062
20072
20084
20093
20108
20114
20125
20135
20143
20153
20167
20174
20189
20194
20204
20215
20228
20238
20243
20253
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed48
Unknown status18
Recruiting16
Terminated15
Active, not recruiting4
Not yet recruiting1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital, Rouen7
Assistance Publique - Hôpitaux de Paris5
Hospices Civils de Lyon5
Institut Bergonié5
Centre Hospitalier Universitaire de Besancon4
Centre Leon Berard4
Institut du Cancer de Montpellier - Val d'Aurelle4
Centre Hospitalier Universitaire de Nīmes3
IHU Strasbourg3
SafeHeal Inc3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colorectal Neoplasms104
Breast Neoplasms13
Lung Neoplasms9
Neoplasms8
Prostatic Neoplasms6
Colonic Neoplasms5
Carcinoma, Non-Small-Cell Lung4
Head and Neck Neoplasms4
Neoplasm Metastasis4
Ovarian Neoplasms4

Trials

Showing 1 to 25 of 104. Each trial links to its page on Pharma Observatory.

4 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.